LBF20503HO09: Difference between revisions
No edit summary |
No edit summary |
||
Line 9: | Line 9: | ||
|Common Name=&&5S-hydroxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid&& | |Common Name=&&5S-hydroxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid&& | ||
|UV Spectra=<FONT FACE="Symbol">l</FONT>max: 236nm <FONT FACE="Symbol">e</FONT>: 23,000 | |UV Spectra=<FONT FACE="Symbol">l</FONT>max: 236nm <FONT FACE="Symbol">e</FONT>: 23,000 | ||
|Source=The synthesis of 5(S)-HEPE from EPA by tissue homogenates has been demonstrated [[Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Kaufman_PL:Srinivasan_BD:,J. Ocul. Pharmacol.,1987,3,349}}]][[Reference:Kulkarni_PS:Srinivasan_BD:,Prostaglandins,1986,31,1159|{{RelationTable/GetFirstAuthor|Reference:Kulkarni_PS:Srinivasan_BD:,Prostaglandins,1986,31,1159}}]];>. | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} |
Revision as of 22:00, 24 November 2009
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | DFA8118 |
LipidMaps | LMFA03070001 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20503HO09 |
5S-hydroxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid | |
---|---|
Structural Information | |
5S-hydroxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid | |
| |
Formula | C20H30O3 |
Exact Mass | 318.21949482599996 |
Average Mass | 318.4504 |
SMILES | C(CC=CCC=CCC=CC=CC(CCCC(O)=O)O)=CCC |
Physicochemical Information | |
The synthesis of 5(S)-HEPE from EPA by tissue homogenates has been demonstrated Kulkarni_PS et al. Kulkarni_PS et al.;>. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | lmax: 236nm e: 23,000 |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|